4.3 Review

Clinical Use of PET/MR in Oncology: An Update

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial

Lukas Kessler et al.

Summary: The study found that novel radiolabeled FAP inhibitors showed high tumor uptake in bone and soft-tissue sarcoma patients, indicating potential applications for clinical diagnosis and treatment.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

The added value of PSMA PET/MR radiomics for prostate cancer staging

Esteban Lucas Solari et al.

Summary: The study evaluated the performance of combined PET and mpMRI radiomics for predicting postsurgical Gleason scores in primary prostate cancer patients. The results showed that the PET + ADC double-modality model performed the best, significantly outperforming other models, and had better predictive ability for psGS compared to biopsy GS.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

Robert Seifert et al.

Summary: This study aimed to evaluate pretherapeutic PSMA PET derived total tumor volume and related metrics as prognosticators of overall survival in patients receiving Lu-PSMA therapy. PSMA-TV was found to be a statistically significant negative prognosticator of overall survival, while PSMA-TLQ was an independent and superior prognosticator compared with PSMA-TV.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Oncology

Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision

Manuel Weber et al.

Summary: The study investigated the feasibility of reducing scanning time or administered tracer activity threefold using a novel digital PET/CT scanner without compromising diagnostic performance. The results showed that this goal can be achieved, which may lead to lower radiation exposure and better health economics for lymphoma patients.

BMC CANCER (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI

L. Papp et al.

Summary: This study utilized PET/MRI radiomics and machine learning to predict lesion risk in primary prostate cancer patients without the need for biopsy sampling. The models showed higher accuracies and AUC values compared to traditional analyses based on PSA, biopsy Gleason score, and TNM staging. The results demonstrate the potential for improving risk classification in prostate cancer patients using advanced imaging techniques and machine learning algorithms.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging

Amirhossein Sanaat et al.

Summary: The study aimed to evaluate the performance of synthesizing regular full-dose PET images from fast/low-dose whole-body PET images using deep learning techniques. The results showed that the predicted full-dose images had almost similar performance in terms of lesion detectability, qualitative scores, and quantification bias and variance.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis

Pierpaolo Biondetti et al.

Summary: This study evaluated the sensitivity of PET/MR compared to PET/CT or CT for lung nodule detection, finding that PET/MR has lower sensitivity for small nodules and may miss some nodules, with some of the missed nodules showing growth on follow-up, likely representing metastases. However, this did not impact clinical management in patients with primary abdominal malignancies.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure

Yan-Ran (Joyce) Wang et al.

Summary: The study utilized a novel artificial intelligence algorithm to generate diagnostic F-18-FDG PET images of pediatric cancer patients from ultra-low-dose input images. The convolutional neural network (CNN) successfully reconstructed standard-dose PET images from simulated ultra-low-dose scans, improving image quality and diagnostic accuracy compared to traditional low-dose scans. The CNN augmentation also led to higher agreement in diagnostic confidence between standard clinical scans and AI-reconstructed PET scans.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Just another Clever Hans? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer

Manuel Weber et al.

Summary: This study evaluated the accuracy of a neural network in detecting metastatic lesions in breast cancer patients, showing high sensitivity and specificity for PERCIST measurable foci. The neural network had high accuracy in determining the anatomical position of lesions and quantifying total tumor volume. The AI-derived whole-body and organ-wise MTV were significant prognosticators of overall survival in advanced breast cancer.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Review Physics, Multidisciplinary

SiPM applications in positron emission tomography: toward ultimate PET time-of-flight resolution

P. Lecoq et al.

Summary: The development of PET/MRI multimodality has led to an increased demand for photodetectors with magnetic field immunity and time-of-flight capabilities, prompting the gradual replacement of traditional photomultipliers in PET scanners with solid-state photodetectors, avalanche diodes (APD), and silicon photomultipliers (SiPM). Recent years have seen significant progress in the performance of SiPMs, making them the preferred choice for a new generation of time-of-flight PET scanners (TOF-PET) due to their improved photodetection efficiency, reduced noise and cross talk, timing performance, and availability in various dimensions and packages.

EUROPEAN PHYSICAL JOURNAL PLUS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer

David Kersting et al.

Summary: This study compared the performance of three generations of PET scanners with different detector technologies in detecting and imaging lesions with low radioiodine uptake. The results suggested that the new generation Biograph Vision PET/CT using TOF-based image reconstruction demonstrated the highest detectability and image quality at a standard acquisition time of 4 minutes per bed position, making it the preferred choice for imaging low-uptake lesions. Prolonged acquisition time for the neck region may be beneficial.

EJNMMI PHYSICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients

Nils Martin Bruckmann et al.

Summary: This study compared the diagnostic performance of different imaging techniques in detecting bone metastases in patients with primary breast cancer. [F-18]FDG PET/MRI and MRI alone showed significantly higher sensitivity and specificity than CT and bone scintigraphy; CT and bone scintigraphy had lower sensitivity in detecting bone metastases and were prone to false-positive results.

EUROPEAN RADIOLOGY (2021)

Review Oncology

Use of PET Imaging in Neuro-Oncological Surgery

Adrien Holzgreve et al.

Summary: The use of positron emission tomography (PET) imaging in neuro-oncological surgery is vital for interpretation of imaging findings, treatment interventions, and surgical planning in patients with glioma, brain metastases, and meningioma. Advances in PET technology, such as amino acid tracers and specific ligands, provide promising perspectives for non-invasive prediction of molecular tumor characteristics, response assessment, and differentiation between tumor progression and treatment-related changes. Further developments in neuro-oncological imaging are expected from new techniques like hybrid PET/MR scanners and artificial intelligence methods.

CANCERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging

Hannes Gruenig et al.

Summary: Improved logistics and availability have led to a rapid increase in the use of [F-18]-PSMA-1007 for prostate cancer PET imaging. Initial data suggest increased uptake in benign lesions compared to [(68)Ga]-PSMA-11, and clinical observations found increased unspecific bone uptake (UBU). UBUs occur in two-thirds of patients imaged with [F-18]-PSMA-1007 PET/CT and are significantly more frequent on digital PET scanners than analog scanners, highlighting the need for careful interpretation to avoid over-staging.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation

Evyn G. Arnfield et al.

Summary: The study found that [F-18]PSMA-1007 avid NSBLs rarely indicate prostate cancer bone metastases. NSBLs with SUVmax < 7.2 were classified as likely benign, while those with SUVmax 7.2-11.1 may be classified as equivocal or metastatic based on patient clinical risk factors, scan appearance, and potential management implications. An SUVmax threshold of >= 7.2 was found to maximize the Youden's index in distinguishing between NSBLs and definite prostate cancer bone metastases.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Editorial Material Urology & Nephrology

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

Louise Emmett et al.

Summary: The combination of PSMA + MRI shows higher negative predictive value and sensitivity for detecting clinically significant prostate cancer compared to MRI alone, but with a lower specificity. Combined PSMA + MRI may help avoid unnecessary prostate biopsies in some men.

EUROPEAN UROLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard

Janna Morawitz et al.

Summary: This study aimed to compare different imaging modalities for detecting axillary lymph node metastases in women with newly diagnosed breast cancer. The results show that F-18-FDG PET/MRI had the highest accuracy in determining axillary lymph node status, while axillary sonography had the highest specificity. In a clinical setting, combining F-18-FDG PET/MRI and axillary sonography may offer even greater diagnostic accuracy.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Medicine, General & Internal

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor et al.

Summary: The radioligand therapy with Lu-177-PSMA-617 prolonged both imaging-based progression-free survival and overall survival in patients with PSMA-positive metastatic castration-resistant prostate cancer when added to standard care. Adverse events were more common with Lu-177-PSMA-617 but did not significantly impact quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Oncology

Evaluation of 68Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving 177Lu-PSMA-617 Therapy: A Radiomics Analysis

Wolfgang Roll et al.

Summary: This study analyzed the predictive and prognostic value of radiomic features from pretherapeutic PSMA PET-MRI and Ga-68-PSMA-11 PET-MRI in advanced prostate cancer patients undergoing PSMA therapy. The radiomic analysis revealed that the interquartile range feature from T2-weighted images showed the highest accuracy in predicting treatment response and survival outcomes.

CANCERS (2021)

Article Oncology

Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding

Lale Umutlu et al.

Summary: This study utilized simultaneous F-18-FDG PET/MRI as a platform for comprehensive radiomics analysis for breast cancer subtype, hormone receptor status, proliferation rate, and metastatic spread, demonstrating high accuracy in predicting these factors. The combination of multiparametric MRI and PET data provided the best results for differentiating between different breast cancer subtypes and predicting hormone receptor status, proliferation rate, and metastatic spread.

CANCERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT

Joyce van Sluis et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Review Urology & Nephrology

Multiparametric MRI for prostate cancer diagnosis: current status and future directions

Armando Stabile et al.

NATURE REVIEWS UROLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL

Benedikt Kranzbuehler et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting

Johannes Haubold et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis

Robert Seifert et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients

Nils Martin Bruckmann et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

LSemiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer

Robert Seifert et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/MRI in adult sarcomas

Gianluca Cassarino et al.

CLINICAL AND TRANSLATIONAL IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy

Andrea Farolfi et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas

Johannes Grueneisen et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Ian Law et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of image quality and lesion detection between digital and analog PET/CT

Diego Alfonso Lopez-Mora et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma

Jiaji Mao et al.

EUROPEAN RADIOLOGY (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

The new opportunities for high time resolution clinical TOF PET

Maurizio Conti et al.

CLINICAL AND TRANSLATIONAL IMAGING (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Matthias Eiber et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

68Ga-Prostate-Specific Membrane Antigen PET/CT in Triple-Negative Breast Cancer

Averilicia Passah et al.

CLINICAL NUCLEAR MEDICINE (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

Onofrio A. Catalano et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical utility of simultaneous whole-body F-18-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma

Sheng-Chieh Chan et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Concurrent Respiratory Motion Correction of Abdominal PET and Dynamic Contrast-Enhanced-MRI Using a Compressed Sensing Approach

Niccolo Fuin et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma

Ashwin Singh Parihar et al.

CLINICAL NUCLEAR MEDICINE (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing F-18-FDG-PET/MRI

Julian Kirchner et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Multidisciplinary Sciences

Predicting IDH genotype in gliomas using FET PET radiomics

Philipp Lohmann et al.

SCIENTIFIC REPORTS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial

Youssef Erfanian et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

Article Oncology

Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast

Onofrio Antonio Catalano et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2017)

Review Clinical Neurology

Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review

Thomas Graillon et al.

JOURNAL OF NEUROSURGERY (2017)

Review Clinical Neurology

Current Clinical Brain Tumor Imaging

Javier E. Villanueva-Meyer et al.

NEUROSURGERY (2017)

Article Oncology

PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype

Onofrio Antonio Catalano et al.

BRITISH JOURNAL OF CANCER (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging

Ivan Platzek et al.

CLINICAL IMAGING (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Outcome of Small Lung Nodules Missed on Hybrid PET/MRI in Patients With Primary Malignancy

Roy A. Raad et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer

Lino M. Sawicki et al.

EUROPEAN JOURNAL OF RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients

Claudio Spicks et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer

Kambiz Rahbar et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomics: Images Are More than Pictures, They Are Data

Robert J. Gillies et al.

RADIOLOGY (2016)

Article Computer Science, Information Systems

A Robust Deep Model for Improved Classification of AD/MCI Patients

Feng Li et al.

IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS (2015)

Review Radiology, Nuclear Medicine & Medical Imaging

Radiation-induced cancer: a modern view

D. J. Shah et al.

BRITISH JOURNAL OF RADIOLOGY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI

Ali Afshar-Oromieh et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI

Norbert Galldiks et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Medicine, General & Internal

IDH1 and IDH2 Mutations in Gliomas

Hai Yan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Oncology

An overview of prognostic factors for long-term survivors of breast cancer

Isabelle Soerjomataram et al.

BREAST CANCER RESEARCH AND TREATMENT (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas

N Galldiks et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)

Article Oncology

Prognostic and predictive factors in early-stage breast cancer

M Cianfrocca et al.

ONCOLOGIST (2004)